Physician Wealth Advisors’s Ingredion INGR Stock Holding History

Physician Wealth Advisors’s Portfolio INGR Stock Details INGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$948	Buy	10 +6	+150%	+$634	﹤0.01%	1864
2026 Q1	$451	Hold	4	–	–	﹤0.01%	1960
2025 Q4	$442	Buy	+4	New	+$451	﹤0.01%	1940

Other funds holding INGR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

YAM

Yacktman Asset Management Austin, Texas $8.09B AUM 19.03% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Physician Wealth Advisors's INGR Position: Q2 2026 in Review

Physician Wealth Advisors increased its Ingredion (INGR) stake by 150% in Q2 2026, buying an estimated $634 and bringing the position to 10 shares worth $948. The position accounts for ﹤0.01% of the portfolio, ranked #1864.

Physician Wealth Advisors first reported a position in INGR in Q4 2025 and has held it in 3 quarters since. 613 funds tracked by Wall St. Rank hold INGR as of Q2 2026.

Physician Wealth Advisors held 10 shares of Ingredion worth $948 as of Q2 2026.
Physician Wealth Advisors bought 6 Ingredion shares in Q2 2026, an estimated $634.
Ingredion made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1864 holding.
Physician Wealth Advisors first reported a position in Ingredion in Q4 2025 and has held it in 3 quarters since.
613 funds tracked by Wall St. Rank held Ingredion as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.